Home/Filings/4/0001209191-19-019222
4//SEC Filing

MALIK NAFEES NASEER 4

Accession 0001209191-19-019222

CIK 0001708599other

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 6:09 PM ET

Size

5.4 KB

Accession

0001209191-19-019222

Insider Transaction Report

Form 4
Period: 2019-03-11
MALIK NAFEES NASEER
Chief Operating Officer
Transactions
  • Award

    Option to Purchase Common Stock

    2019-03-11+70,00070,000 total
    Exercise: $4.28Exp: 2029-03-10Common Stock (70,000 underlying)
Footnotes (1)
  • [F1]One quarter shall vest on March 11, 2020 and the remaining shall vest monthly over 36 months, based upon continuous service.

Issuer

AgeX Therapeutics, Inc.

CIK 0001708599

Entity typeother

Related Parties

1
  • filerCIK 0001760274

Filing Metadata

Form type
4
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 6:09 PM ET
Size
5.4 KB